Sharechat Logo

Craigs: sell Summerset, buy Gentrack and Scales

Monday 8th April 2019

Text too small?

Craigs Investment Partners is recommending investors sell shares in retirement village operator Summerset Group and to buy shares in utilities software provider Gentrack.

The broking firm, which has a nationwide retail network, is also recommending investors buy shares in Scales, which owns the Mr Apple business.

Gentrack shares were last week's best performer within the benchmark S&P/NZX 50 Index, gaining 9.3 percent, while Summerset was the worst performer, shedding 8 percent.

Craigs says Gentrack faces short-term headwinds but is a quality business which services more than 220 utilities in more than 30 countries, that Scales is focused on building a quality business with high margins but that Summerset is facing a stalling housing market.

“We have continued to highlight our caution on the retirement village sector, particularly in the face of slowing house price inflation,” their recommendation to clients at the end of March says.

“Despite the recent pull-back across the sector, we continue to reiterate this caution.”

In the past six months, Summerset shares have dropped 20 percent while the index has climbed 7 percent.

“For us, structural drivers including an aging population, are overridden by our cautious view of the housing market,” Craigs says.

New Zealand house prices, excluding Auckland, were up 8.1 percent in February from a year earlier but prices in Auckland were down 2 percent and sales volumes throughout the country were down 9.5 percent in a month that usually sees strong activity.

“Our sector exposure reduces to 8 percent from 12 percent. Our decision to move to just one name highlights our view that Ryman is the highest quality operator in the sector,” it says. Should investors want to gain that 8 percent weighting through Ryman and other stocks in the sector, “we are comfortable with that.”

Shares in Ryman, which has a growing exposure to the Melbourne housing market, have fallen nearly 11 percent in the past six months.

House prices in Melbourne have dropped 8 percent from their peak in late 2017 while Sydney prices are down more than 12 percent since their mid-2017 peak. Commentators are picking falls of 15-25 percent before the Australian market bottoms.

Craigs says that although margins in the retirement sector are likely to contract on the resale of units, “prices need to fall for a sustained period of time, given that embedded gains over recent years provide a buffer before any operator is likely to post a loss on a unit.”

Ryman is the largest company in the sector with about 10,000 units or beds. They range from hospital and dementia care beds through to assisted and independent living units and the firm has far more care beds than any of its competitors. Summerset has more than 4,000 units or beds.

Craigs estimates the five listed aged care providers account for about 40 percent of the sector and that Ryman has a 14.6 percent share, followed by Metlifecare with 6.9 percent and Summerset with 6.7 percent. Bupa, which isn't listed, is the second-largest operator with 8.3 percent.

About 89 percent of Gentrack’s revenue now comes from offshore and 40 percent of it from Britain and 30 percent from Australia, Craigs says.

It notes the company has been acquisitive lately, buying Junifer, a software as a service billing systems provider, in April 2017 for $75 million. It bought Bliptrack, an airport passenger tracker and movement predictor, for $8 million that same month, CA+, which manages and audits airport retail concession revenue, for $12 million in May 2017 and Evolve, which extends its settlement and billing offering, for $44 million in June 2018.

“Following a recent equity raise of $90 million, Gentrack has considerable balance sheet capacity if it chooses to pursue further M&A.”

Scales operates in the horticulture sector, and will therefore inherently always have an element of agricultural risk, and its current strategy reset is to grow and market its own premium varieties, in particular those aimed at the Asian consumer.

“We like the company’s focus on building a strong brand, its focus on appropriate capital allocation and its growing tilt towards premium varietals,” Craigs says.

“Scales has announced its orchard development programme, which will reduce near-term volumes through removing lower-returning traditional varieties such as braeburn and replanting higher returning varietals,” it says. That will mean current volumes won’t be matched until the 2023 financial year.

While more than half Scales’ operating earnings come from horticulture, it is growing its food ingredients business and downsizing its storage and logistics operations.

Following the $151 million sale of its Polacold business, Scales will be in a strong net cash position and one uncertainty is how it will apply this cash.

“We take some comfort that Scales will continue to be an efficient capital allocator, based on recent deals,” Craigs says, citing the US$23.2 million acquisition in December of the US-based pet food company Shelby.

That purchase recycles capital from the lower-returning storage business into an "attractive, higher-returning pet food business that it can now operate at scale.”

(BusinessDesk)

  General Finance Advertising    

Comments from our readers

No comments yet

Add your comment:
Your name:
Your email:
Not displayed to the public
Comment:
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Related News:

MARKET CLOSE: NZ shares rise; trading quiet ahead of upcoming earnings
NZ dollar firms against the Aussie heading into federal election
Fletcher-commissioned Deloitte report shows building material costs are low
RBNZ censures ANZ, prescribes risk capital calculation
RBNZ censures ANZ, prescribes risk capital calculation
SeaDragon shareholders back $4M injection to stave off liquidation
SeaDragon shareholders back $4M injection to stave off liquidation
Businesses get some reprieve in March quarter on cheaper prices
NZ manufacturing activity expands on month in April but down on year
Xero's CEO says it still has a cautious future in the US

IRG See IRG research reports